Cite
HARVARD Citation
Lucas, J. et al. (2022). Revised clinical and molecular risk strata define the incidence and pattern of failure in medulloblastoma following risk-adapted radiotherapy and dose-intensive chemotherapy: results from a phase III multi-institutional study. Neuro-oncology. 24 (7), pp. 1166-1175. [Online].